Lucid Diagnostics (LUCD) Preferred Shares (2023 - 2026)

Lucid Diagnostics has reported Preferred Shares for 4 years, with the latest figure at $10.1 million in Q1 2026.

• For the quarter ending Q1 2026, Preferred Shares fell 81.38% year-over-year to $10.1 million; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (down 81.38% YoY), and the FY2025 full-year result was $54.3 million, changed 0.27% from the prior year.
• Preferred Shares for Q1 2026 stood at $10.1 million, down from $54.3 million in the prior quarter.
• The five-year high for Preferred Shares was $55.9 million in Q2 2024, with the low at $10.1 million in Q1 2026.
• Historically, Preferred Shares has averaged $38.3 million across 4 years, with a median of $54.3 million in 2025.
• Annual changes were most pronounced in 2024 — Preferred Shares soared 310.41% — and 2026, when it plunged 81.38%.
• Lucid Diagnostics' Preferred Shares stood at $18.6 million in 2023, then jumped by 192.18% to $54.4 million in 2024, then decreased by 0.27% to $54.3 million in 2025, then plunged by 81.33% to $10.1 million in 2026.
• The last three Preferred Shares figures came in at $10.1 million (Q1 2026), $54.3 million (Q4 2025), and $54.3 million (Q3 2025), per Business Quant data.